About Genlink Pharma Solutions Private Limited
Data last updated: 25 February 2026
Genlink Pharma Solutions Private Limited is a private limited company based in Thane, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 06 May 2016, the company has been in operation for over 10 years.
Registered with ROC Mumbai under CIN U74999MH2016PTC280765.
Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. Formerly known as Genlink Pharma Services Private Limited and Genlink Pharma Investments Private Limited. It is led by directors Avani Anand Shah and Anand Prafulchandra Shah.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Sector 19, Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹83.63 Lakh, a growth of 78% compared to the previous year.
The company is associated with 1 brand - Genlink Pharma Solutions. As per MCA filings, the company has open charges of ₹49.5 Cr and satisfied charges of ₹52.41 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genlinkpharma.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address401 4Th Floor Kesar Solitaire, Plot No. 5 Sector 19 Sanpada Navi Mumbai 400705, Thane, Maharashtra, India – 400705
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Genlink Pharma Solutions Private Limited
Genlink Pharma Solutions Private Limited has undergone 3 name changes throughout its history. The company was previously known as Genlink Pharma Services Private Limited, Genlink Pharma Investments Private Limited, and Genlink Pharmaserv Private Limited. The current legal name is Genlink Pharma Solutions Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Genlink Pharma Solutions Private Limited | Current |
| Genlink Pharma Services Private Limited | Previous |
| Genlink Pharma Investments Private Limited | Previous |
| Genlink Pharmaserv Private Limited | Previous |
CIN History of Genlink Pharma Solutions Private Limited
Genlink Pharma Solutions Private Limited has one previous CIN (Corporate Identification Number): U74999MH2016PTC280765. The current CIN is U74110MH2016PTC280765, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110MH2016PTC280765 | Current |
| U74999MH2016PTC280765 | Previous |
Associated Brands with Genlink Pharma Solutions Private Limited
Genlink Pharma Solutions Private Limited operates one associated brand: Genlink Pharma Solutions. These brands represent Genlink Pharma Solutions Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides consultancy, trading, distribution, marketing, and R&D for pharma products. | genlinkpharma.com |
Competitors & Alternatives of Genlink Pharma Solutions Private Limited
Brands and companies operating in the same space as Genlink Pharma Solutions Private Limited include Indegene, Zuellig Pharma, IntegriChain and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Indegene
|
Suite solutions are provided for payers and healthcare providers. | Princeton, United States, United States | 1998 |
Zuellig Pharma
|
Healthcare access in Asia is enhanced by Zuellig Pharma. | Singapore, Singapore, Singapore | 1992 |
IntegriChain
|
Inventory, order and customer relationship management solution for life science suppliers. | Philadelphia, United States, United States | 2005 |
Clinigen
|
Specialty medicines are supplied via clinical trials and access programs. | Burton-on-trent, United Kingdom, United Kingdom | 2010 |
ClearView Healthcare Partners
|
Strategic consulting services are provided to life sciences companies. | Newton, United States, United States | 2008 |
Fabtech
|
Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. | Mumbai, India, India | 2002 |
Science Group
|
Technology-based consultancy and product development services are provided. | Cambridge, United Kingdom, United Kingdom | 1995 |
Business Activity of Genlink Pharma Solutions Private Limited
Genlink Pharma Solutions Private Limited is engaged in the principal business activity of real estate, with detailed activities including real estate activities with own or leased property.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property | ********* |
Board of Directors of Genlink Pharma Solutions Private Limited
Genlink Pharma Solutions Private Limited is currently managed by 3 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avani Anand Shah | Director | 15 Jan 2019 | 7 Years 5 Months | Current |
| Anand Prafulchandra Shah | Director | 06 May 2016 | 10 Years 2 Months | Current |
Financials of Genlink Pharma Solutions Private Limited FY 2025 filings available
Genlink Pharma Solutions Private Limited reported revenue of ₹83.63 Lakh (up 78% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Genlink Pharma Solutions Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2019 | Others | ₹24.5 Cr | Satisfied |
| 16 Nov 2018 | Axis Bank Limited | ₹2.91 Cr | Satisfied |
| 17 Mar 2017 | Others | ₹25 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Genlink Pharma Solutions Private Limited
View historical data on people associated with Genlink Pharma Solutions Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Genlink Pharma Solutions Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Genlink Pharma Solutions Private Limited
GSTIN & GST Filing Data of Genlink Pharma Solutions Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Genlink Pharma Solutions Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Genlink Pharma Solutions Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Genlink Pharma Solutions Private Limited
MSME Payment Delays by Genlink Pharma Solutions Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Genlink Pharma Solutions Private Limited
Subsidiaries & Group Companies of Genlink Pharma Solutions Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Genlink Pharma Solutions Private Limited with ownership details.
MCA Filings & Documents of Genlink Pharma Solutions Private Limited
MCA Filings & Documents of Genlink Pharma Solutions Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Genlink Pharma Solutions Private Limited
Frequently Asked Questions about Genlink Pharma Solutions Private Limited
Genlink Pharma Solutions Private Limited is an active private limited company in the pharma sector based in Thane, Maharashtra, India. It was incorporated on 06 May 2016 (10+ years old) and is registered under CIN U74110MH2016PTC280765.
Genlink Pharma Solutions Private Limited reported revenue of ₹83.63 Lakh for FY 2025 (up 78.00% YoY).
The current directors of Genlink Pharma Solutions Private Limited are:
- Avani Anand Shah
- Anand Prafulchandra Shah
- Chaitali Jayant Gawkar
The primary industry of Genlink Pharma Solutions Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Genlink Pharma Solutions Private Limited can be reached at the registered office: 401 4Th Floor Kesar Solitaire, Plot No. 5 Sector 19 Sanpada Navi Mumbai 400705, Thane, Maharashtra, India – 400705, or through the website genlinkpharma.com.
The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.